Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...

Verona Pharma stock hit a record high Thursday on continued enthusiasm for its newly launched COPD treatment, Ohtuvayre.

The following is a summary of “Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe ...

For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

HealthDay News — There is a bidirectional association between rheumatoid arthritis (RA) and chronic obstructive pulmonary ...

Yet, when medical researcher Serge Renaud argued in the early 1990s that French people’s regular, moderate consumption of red wine led to better cardiovascular health, the world quickly embraced this ...

The study included 20,388 propensity score-matched pairs of new users. The researchers found that the incidence of a first moderate or severe COPD exacerbation was higher in patients who received ...

Let’s face it, the Democratic Party got off track. Back in the late ’90s, President Bill Clinton had approval ratings in the 70s as the party stood for a form of centrist progressivism. It ...

The therapy is used along with other PAH medications to improve exercise capacity in patients with moderate to severe limitations in physical activity. Designed to address the underlying causes of PAH ...